Proyecto de Investigación Internacionales
IMID-VAC, an App designed to improve the knowledge about vaccination and improve immunization rates in patients with chronic immune-mediated inflammatory disorders. Second stage: IMID-VAC 2.0, worldwide amplification in the digital era
Volver a proyectos12/11/2021 - 31/05/2024
Descripción
Our project is an extension of the previous project IMID-VAC App that was an educational and quality improvement program that aimed to improve the knowledge about the need for vaccination and to increase the rate of appropriate vaccinations according to the current recommendations, in patients with chronic immune-mediated inflammatory rheumatic diseases. Since then, an update of the EULAR (European League Against Rheumatism) recommendations for vaccination in adult patients with these diseases was published and new vaccines are at their disposal but, above all, the COVID-19 pandemic justifies a new perspective of our project. First, there is an evident need for increasing the knowledge of these patients about immunization (and specifically, about the different aspects of COVID-19 vaccines). Secondly, the current situation is making the face-to-face dissemination of our first project difficult and challenging. Finally, the great variety of modern communication strategies that currently are at our disposal lead us to design IMID-VAC 2.0.
Goal: To internationally amplify the divulgation of IMID-VAC App by translating it into English and applying a variety of the new communication strategies.
Características
| Código | IMID-VAC 2.0. |
|---|---|
| Fecha de inicio | 12/11/2021 |
| Fecha de finalización | 31/05/2024 |
| Investigador responsable | J.M. Pego Reigosa |
| Centro de realización | Hospital Meixoeiro (Área Sanitaria de Vigo). Servicio de Reumatología |
| Entidad financiación | Pfizer Independent Grants for Learning & Change |
| Importe financiación | 130.873,95 € |
